+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Bronchodilation and bronchoprotection in asthmatic preschool children from formoterol administered by mechanically actuated dry-powder inhaler and spacer



Bronchodilation and bronchoprotection in asthmatic preschool children from formoterol administered by mechanically actuated dry-powder inhaler and spacer



American Journal of Respiratory and Critical Care Medicine 164(2): 256-259



We evaluated the bronchodilatory and the bronchoprotective effect of the long-acting beta(2)-agonist formoterol administered as dry powder from a mechanically actuated dry-powder inhaler (DPI) using spacer in 12 asthmatic children 2 to 5 yr of age. Lung function was measured as the specific airway resistance (sRaw) in a whole body plethysmograph. Hyperventilation of cold, dry air was used as bronchial challenge, and the responsiveness was estimated as change in sRaw. The bronchoprotective effect of formoterol Turbohaler 9 microg was compared with salbutamol 200 microg and placebo at 15 min, 4 and 8 h postdose in a randomized, double-blind, placebo-controlled, crossover study. All treatments were administered from DPI (Turbohaler) actuated mechanically into a spacer. Formoterol and salbutamol caused similar and significant bronchodilation at the first measurement 3 min postdose. Formoterol offered a sustained and stable bronchodilation for at least 8 h. Salbutamol provided significant bronchodilation for less than 4 h. Formoterol caused significant bronchoprotection of 80% for at least 8 h compared with placebo, and from 4 h onward compared with salbutamol. Bronchoprotection from salbutamol lasted less than 4 h. In conclusion, formoterol administered as dry powder in a single dose provided rapid and sustained bronchodilation and clinically significant bronchoprotection for at least 8 h in 2- to 5-yr-old asthmatic children. Furthermore, this study suggests that mechanical actuation of DPI using a spacer is effective for aerosol treatment of young asthmatic children.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010259166

Download citation: RISBibTeXText

PMID: 11463597

DOI: 10.1164/ajrccm.164.2.2011121


Related references

Bronchodilation with mometasone furoate/formoterol fumarate administered by metered-dose inhaler with and without a spacer in children with persistent asthma. Pediatric Pulmonology 49(5): 441-450, 2014

Comparison of inhaled terbutaline administered by either the Turbuhaler dry powder inhaler or a metered-dose inhaler with spacer in preschool children with asthma. Journal Of Pediatrics. 124(5 Part 1): 815-817, 1994

Use of formoterol dry powder administered for three months via a single-dose inhaler in 1,380 asthmatic patients. Journal of Investigational Allergology & Clinical Immunology 8(5): 265-270, 1998

Formoterol delivered via a new multi-dose dry powder inhaler (Certihaler) is as effective and well tolerated as the formoterol dry powder inhaler (Aerolizer) in children with persistent asthma. Journal of Aerosol Medicine 18(1): 63-73, 2005

Comparable efficacy and tolerability of formoterol (Foradil) administered via a novel multi-dose dry powder inhaler (Certihaler) or the Aerolizer dry powder inhaler in patients with persistent asthma. Respiration; International Review of Thoracic Diseases 71(2): 126-133, 2004

Comparative efficacy of terbutaline sulfate delivered by Turbuhaler dry powder inhaler or pressurised metered dose inhaler + Nebuhaler spacer in children during an acute asthmatic episode. European Respiratory Journal 12(SUPPL 28): 379S, Sept, 1998

Comparative efficacy of terbutaline sulphate delivered by Turbuhaler dry powder inhaler or pressurised metered dose inhaler with Nebuhaler spacer in children during an acute asthmatic episode. Archives of Disease in Childhood 88(4): 319-323, 2003

Adrenal suppression in asthmatic children receiving low-dose inhaled budesonide: comparison between dry powder inhaler and pressurized metered-dose inhaler attached to a spacer. Annals of Allergy, Asthma & Immunology 89(6): 566-571, 2002

Long-term efficacy and resource utilization after treatment with budesonide and formoterol administered via one pressurized metered-dose inhaler (pMDI) compared with budesonide dry powder inhaler (DPI) alone in children with asthma. Journal of Allergy and Clinical Immunology 121(2-supp-S1), 2008

Comparison of a multidose powder inhaler containing beclomethasone dipropionate (BDP) with a BDP metered dose inhaler with spacer in the treatment of asthmatic patients. Clinical Drug Investigation 16(2): 101-110, 1998

Comparison of a Multidose Powder Inhaler Containing Beclomethasone Dipropionate (BDP) with a BDP Metered Dose Inhaler with Spacer in the Treatment of Asthmatic Patients. Clinical Drug Investigation 16(2): 101-110, 2008

Assessment of skills using a spacer device for a metered-dose inhaler and related independent predictive factors in caregivers of asthmatic preschool children. International Forum of Allergy & Rhinology 6(2): 130-134, 2016

Cost-effectiveness of fluticasone propionate administered via metered-dose inhaler plus BabyhalerTM spacer in the treatment of asthma in preschool-aged children. Chest 120(6): 1835-1842, December, 2001